Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
14.60
+0.51 (3.62%)
Dec 5, 2025, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 421 | 256 | 220 | 235 | 1,075 | 1,148 | |
| Market Cap Growth | 111.12% | 16.57% | -6.67% | -78.12% | -6.39% | 24.98% | |
| Enterprise Value | 434 | 259 | 173 | 73 | 809 | 784 | |
| Last Close Price | 14.60 | 11.97 | 10.36 | 11.17 | 51.87 | 56.81 | |
| PS Ratio | 4.77 | 3.92 | 3.25 | 2.97 | 12.48 | 11.83 | |
| PB Ratio | 4.82 | 3.95 | 1.70 | 1.09 | 3.35 | 2.88 | |
| P/TBV Ratio | 6.51 | 3.95 | 1.70 | 1.09 | 3.35 | 2.88 | |
| EV/Sales Ratio | 6.64 | 3.96 | 2.56 | 0.93 | 9.39 | 8.08 | |
| Debt / Equity Ratio | 3.11 | 3.11 | 1.76 | 1.03 | 0.08 | 0.02 | |
| Asset Turnover | 0.20 | 0.20 | 0.16 | 0.19 | 0.21 | 0.21 | |
| Quick Ratio | 4.03 | 4.03 | 4.99 | 6.52 | 10.00 | 8.43 | |
| Current Ratio | 4.21 | 4.21 | 5.21 | 6.73 | 10.45 | 8.82 | |
| Return on Equity (ROE) | -84.63% | -84.63% | -67.16% | -49.74% | -33.78% | -18.48% | |
| Return on Assets (ROA) | -16.23% | -16.23% | -18.13% | -20.47% | -19.01% | -14.81% | |
| Return on Capital (ROIC) | -17.19% | -17.19% | -19.16% | -21.79% | -20.52% | -15.72% | |
| Return on Capital Employed (ROCE) | -36.80% | -36.80% | -38.10% | -34.30% | -35.80% | -27.20% | |
| Earnings Yield | -19.43% | -32.00% | -52.86% | -56.90% | -11.33% | -6.88% | |
| FCF Yield | -7.63% | -12.57% | -44.06% | -47.71% | -8.08% | -6.16% | |
| Buyback Yield / Dilution | -0.85% | -0.85% | -0.90% | -1.78% | -2.14% | -1.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.